Printer Friendly

DIAGNON REPORTS THIRD QUARTER RESULTS

 DIAGNON REPORTS THIRD QUARTER RESULTS
 ROCKVILLE, Md., April 14 /PRNewswire/ -- Diagnon Corporation


reported results for its third quarter:
 Third Quarter Ended Feb. 29: 1992 1991
 Revenues $2,190,266 $1,277,116
 Net Income $ 28,359 $ 79,353
 Earnings Per Share $ .01 $ .02
 Number of Shares Outstanding 5,398,244 5,111,577
 Nine Months Ended Feb. 29:
 Revenues $6,163,706 $3,765,111
 Net Income $ 195,864 $ 170,773
 Earnings Per Share $ .04 $ .03
 Number of Shares Outstanding 5,398,244 5,911,087
 On April 1, 1992, BIOQUAL, Inc., was selected by the National Heart, Lung and Blood Institute (NHLBI) to provide services needed to implement transgenic virus therapy for cystic fibrosis in primates. This work is key in the evaluation of the development of gene therapy for cystic fibrosis using the newly engineered adenovirus containing the "cystic fibrosis gene." The NHLBI has been instrumental in the research leading toward this therapeutic approach.
 -0- 4/14/92
 /CONTACT: John C. Landon, chief executive officer, Diagnon Corporation, 301-251-2801/ CO: Diagnon Corporation ST: Maryland IN: MTC SU:


MH-DC -- DC027 -- 8244 04/14/92 11:45 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 14, 1992
Words:187
Previous Article:PAINEWEBBER GROUP REPORTS FIRST QUARTER RESULTS; EARNINGS INCREASE 135 PERCENT; FIFTH CONSECUTIVE QUARTERLY INCREASE IN PROFITS
Next Article:HEALTH IMAGES OPENS COMPANY'S SECOND INTERNATIONAL MRI CENTER


Related Articles
DIAGNON CORPORATION REPORTS RESULTS
DIAGNON CORPORATION REPORTS RESULTS FOR ITS FIRST QUARTER
DIAGNON REPORTS SECOND QUARTER RESULTS
DIAGNON CORPORATION REPORTS THIRD QUARTER RESULTS
DIAGNON CORPORATION REPORTS RESULTS FOR ITS FIRST QUARTER
DIAGNON CORPORATION REPORTS RESULTS FOR ITS THIRD QUARTER
DIAGNON CORPORATION REPORTS RESULTS FOR ITS FIRST QUARTER
DIAGNON CORPORATION REPORTS RESULTS FOR ITS THIRD QUARTER
DIAGNON CORPORATION REPORTS FIRST QUARTER RESULTS
Diagnon Corporation Reports Results for its Third Quarter

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters